Form 4 for SMTI Sanara MedTech Inc.
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-12 · accession 0001493152-23-012318 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | 2023-04-12 | SMTI | McNeil Michael D. | CFO | M - OptEx | $6.00 | +1,000 | 23.0K | +5% | +$6,000 |
| D | 2023-04-14 | 2023-04-12 | SMTI | McNeil Michael D. | CFO | M - OptEx | $0.00 | -1,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-12 | M | A | 1,000 | $6.00 | 23,025 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-04-12 | M | D | 1,000 | $0.00 | 0 | D | $6.00 · — to 2023-04-13 | 1,000 Common Stock | (F1) Pursuant to the terms of the option award agreement, the option vested in full on March 15, 2019 in connection with the closing of the Share Exchange Agreement between the issuer and CGI Cellerate RX, LLC, which was deemed to be a change of control of the issuer. |